Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor

Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
Journal of Nuclear Medicine March 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Jie Ding
1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anli Tong
2Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yushi Zhang
3Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Wen
3Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhang
4Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
5Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Huo
1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Li
5Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 3 368-375
DOI 
https://doi.org/10.2967/jnumed.121.261964
PubMed 
34301781

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 16, 2021
  • Revision received June 3, 2021
  • Published online March 1, 2022.

Article Versions

  • previous version (July 22, 2021 - 14:50).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Jie Ding1,
  2. Anli Tong2,
  3. Yushi Zhang3,
  4. Jin Wen3,
  5. Hui Zhang4,
  6. Marcus Hacker5,
  7. Li Huo1 and
  8. Xiang Li5
  1. 1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  2. 2Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  3. 3Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  4. 4Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
  5. 5Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
  1. For correspondence or reprints, contact Li Huo (huoli{at}pumch.cn).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 25 Citations
  • 27 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET/CT
    Yinjie Gao, Jie Ding, Yunying Cui, Tianyi Li, Hao Sun, Dachun Zhao, Yushi Zhang, Li Huo, Anli Tong
    European Radiology 2022 33 2
  • Usefulness of 68Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome
    Jie Ding, Anli Tong, Marcus Hacker, Ming Feng, Li Huo, Xiang Li
    Clinical Nuclear Medicine 2022 47 8
  • Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor
    Liza Lindenberg, Mark Ahlman, Frank Lin, Esther Mena, Peter Choyke
    Seminars in Nuclear Medicine 2024 54 1
  • Clinical Value of68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
    Jie Ding, Xiang Li, Shengyan Liu, Yinjie Gao, Guoyang Zheng, Marcus Hacker, Yushi Zhang, Anli Tong, Li Huo
    Journal of Nuclear Medicine 2024 65 1
  • A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism
    Xuan Yin, Kai Ai, Jianguang Luo, Wei Liu, Xiaowei Ma, Lianbo Zhou, Xin Xiang, Xin Su, Yunhua Wang, Yuan Li
    Frontiers in Endocrinology 2024 15
  • Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease
    Zhenying Chen, Qianqian Xue, Shaobo Yao
    Mini-Reviews in Medicinal Chemistry 2023 23 7
  • Advances in the molecular imaging of primary aldosteronism
    Xinyi Ren, Gang Cheng, Zhengjie Wang
    Annals of Nuclear Medicine 2023 37 8
  • Integrated 68Ga-Pentixafor and 68Ga-FAPI-04 PET/MR for Diagnosing Adrenal Aldosterone-Producing Adenoma and Accessory Splenic Nodules
    Jie Ding, Weilun Wang, Xing Chen, Zhiwen You, Jun Zhao
    Clinical Nuclear Medicine 2024 49 12
  • Optimal and novel imaging of the adrenal glands
    Patrick J. Navin, Michael R. Moynagh
    Current Opinion in Endocrinology, Diabetes & Obesity 2022 29 3
  • Typing diagnostic value of 68Ga-pentixafor PET/CT for patients with primary aldosteronism and unilateral nodules
    Rui Zuo, Shuang Liu, Xinyi Ren, Wenbo Li, Zhu Xia, Lu Xu, Hua Pang
    Endocrine 2024 87 1

Article usage

Article usage: July 2021 to May 2025

AbstractFullPdf
Jul 202163408
Aug 2021505017
Sep 202131708
Oct 2021715011
Nov 202131604
Dec 2021303010
Jan 2022144016
Feb 2022101024
Mar 2022703520142
Apr 202215524363
May 20229220544
Jun 202217117919
Jul 202243739
Aug 2022274413
Sep 20224229031
Oct 20223024741
Nov 20222911334
Dec 20223238723
Jan 20231937715
Feb 20231637668
Mar 20232338761
Apr 2023828225
May 20231119126
Jun 20231322632
Jul 2023822321
Aug 20231429726
Sep 20231431138
Oct 2023313639
Nov 20231312125
Dec 2023377337
Jan 2024814314
Feb 20241520123
Mar 2024516258
Apr 2024257330
May 202486437
Jun 2024346043
Jul 20248511450
Aug 20249012045
Sep 2024395542
Oct 2024215328
Nov 2024105530
Dec 2024124138
Jan 202595431
Feb 202598643
Mar 202585648
Apr 2025146743
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (3)
Journal of Nuclear Medicine
Vol. 63, Issue 3
March 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor
Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo, Xiang Li
Journal of Nuclear Medicine Mar 2022, 63 (3) 368-375; DOI: 10.2967/jnumed.121.261964

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor
Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo, Xiang Li
Journal of Nuclear Medicine Mar 2022, 63 (3) 368-375; DOI: 10.2967/jnumed.121.261964
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?
  • Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • adrenocortical masses
  • endocrine hypertension
  • 68Ga-pentixafor
SNMMI

© 2025 SNMMI

Powered by HighWire